About The Hepatitis Fund
We provide grants, build financing partnerships, provide technical support on health financing, and advocate for increased national and international funding to eliminate viral hepatitis now.
We allocate resources based on operational excellence, careful impact assessment and the use of best grant-making practices.
Learn more about our Strategic Plan 2022 – 2027 and 2021 Activity Report.
THF Global Ambassador
Rt Hon. Helen Clark, former Prime Minister of New Zealand and former Administrator of UNDP, is the Global Ambassador of The Hepatitis Fund.
Helen Clark was Prime Minister of New Zealand from 1999–2008 and a Member of Parliament for 27 years. She advocated strongly for economic and social justice, sustainability and climate action, and for multilateralism. Helen served two terms as Administrator of the United Nations Development Programme (UNDP) and as Chair of the United Nations Development Group from 2009-2017. Earlier, Helen taught in the Political Studies Department of the University of Auckland, from which she had graduated with BA and MA (Hons) degrees.Helen advocates for sustainable development, climate action, gender equality and women’s leadership, peace and justice, and action on pressing global health issues. In July 2020, she was appointed by the Director-General of the World Health Organisation as Co-Chair of the Independent Panel for Pandemic Preparedness and Response. She chairs the boards of the Extractive Industries Transparency Initiative, the Partnership for Maternal, Newborn and Child Health, and other public good organisations and initiatives.
Board of directors
Executive team
Advisory Council
The scope of Tour activities spans numerous hepatitis prevention and care interventions that target different populations in a wide range of geographical settings. Our Advisory Council members are experts in key programmatic aspects of hepatitis prevention and care and are representative of the key populations affected by hepatitis and regions heavily affected by hepatitis.
Joan Block
Retired executive director, Hepatitis B Foundation
Saeed Hamid
Co-chair, Coalition to Eradicate Viral Hepatitis in Asia Pacific
Homie Razavi
Executive director, Center for Disease Analysis Foundation
Lewis Roberts
Director, Gastroenterology and Hepatology Cancer Center at the Mayo Clinic
Shin Young-Soo
Director emeritus, WHO Western Pacific Regional Office
Su Wang
Medical Director, Viral Hepatitis Programs
ZeShan Foundation
Steering and Oversight Committees
We thank members of the EndHep2030 steering committee and oversight committee who supported the emergence of this initiative.
We thank our past President and co-Founder, Mr Wangsheng LI, for leading The Hepatitis Fund through numerous changes and challenges these past two and a half years.
Oversight Committee members
The Oversight Committee was active from November 2017 – December 2019. It was created as the managing body for EndHep2030 as an RPA-sponsored project.
Steering Committe members
The Steering Committee was created to stand up the EndHep2030 project. It was in commission from November 2016 through October 2017. The Steering Committee accomplished its mandate upon the launch of EndHep2030 in 2017.
Manal El-Sayed
Professor of Pediatrics at Ain Shams University.
Marc Bulterys
Director WHO Global Hepatitis Programme
Charles Gore
Executive Director Medicines Patent Pool
Jinlin Hou
Chairman and Professor of the Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University.
Rana Hajjeh
Director Department of Communicable Disease Prevention and Control, WHO Regional Office for the Eastern Mediterranean
Paul Kuehnert
Vice President, Program Robert Woods Johnson Foundation
Ying-ru Jacqueline Lo
Team Lead HIV, Hepatitis & STD, WHO Western Pacific Regional Office
Lillian Lou
Executive Director The John C. Martin Foundation
Tony Lee
Director and Partner Social Sector Practice, McKinsey & Company
Judith Monroe
president and CEO of the CDC Foundation.
Nicole M. Smith
Associate Director for Policy & Communication for the Division of Viral Hepatitis at the U.S. CDC.
Isabelle Mayer-Andrieux
Viral Hepatitis Advisor Médecins Sans Frontières
Annette Sohn
Executive Director TreatAsia, amfAR
Kathrine Meyers
Director for China Program Aaron Diamond AIDS Research Center at the Rockefeller University
Mike van der Ven
Director Pivotal Ventures, Bill and Melinda Gates Foundation
Nick Walsh
Medical Officer (Viral Hepatitis) WHO Consultant
Stefan Wiktor
Founding Director (retired) WHO Global Hepatitis Programme
John Ward
Director Coalition for Global Hepatitis Elimination
David Wilson
Program director, World Bank’s Health, Population and Nutrition global practice.